Evidence map›Paper›PMID 39541084›Full record

ArticleAdvances in therapy2025

Correction to: Inside ANEMIA of CKD: Projecting the Future Burden of Anemia of Chronic Kidney Disease and Benefits of Proactive Management: A Microsimulation Model of the Chinese Population.

Lise Retat, Dunming Xiao, Laura Webber, Alexander Martin, Joshua Card-Gowers, Jiaqi Yao, Yuzheng Zhang, Chalet Zhang, Juan Jose Garcia Sanchez, Claudia Cabrera and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Lise RetatHealthLumen Limited, London, UK.ORCID http://orcid.org/0000-0002-6689-3599
Dunming XiaoSchool of Public Health, Fudan University, Shanghai, China.
Laura WebberHealthLumen Limited, London, UK.ORCID http://orcid.org/0000-0002-8976-1919
Alexander MartinHealthLumen Limited, London, UK.ORCID http://orcid.org/0009-0001-4863-3961
Joshua Card-GowersHealthLumen Limited, London, UK.
Jiaqi YaoChina Health Economics, Biopharmaceuticals, AstraZeneca, Beijing, China.
Yuzheng ZhangChina National Health Development Research Center, Beijing, China.
Chalet ZhangChina Health Economics, Biopharmaceuticals, AstraZeneca, Beijing, China.
Juan Jose Garcia SanchezGlobal Health Economics, BioPharmaceuticals, AstraZeneca, Cambridge, UK.ORCID http://orcid.org/0000-0001-6546-7769
Claudia CabreraReal World Science and Analytics, Global BioPharmaceuticals Medicine, AstraZeneca, Gothenburg, Sweden.ORCID http://orcid.org/0000-0003-2778-1604
Susan GrandyBioPharmaceuticals Medical, AstraZeneca, Wilmington, USA.
Naveen RaoGlobal Health Economics, BioPharmaceuticals, AstraZeneca, Cambridge, UK.
Yiqing WuMedical Affairs, FibroGen China, Shanghai, China.
Zuo LiPeking University People's Hospital, Beijing, China. zuolimd@hotmail.com.
Jianwei XuanSun Yat-Sen University, Guangzhou, China. xuanjw3@mail.sysu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39541084
PMCPMC11782332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.